TuHURA Biosciences, Inc. Share Price

TuHURA Biosciences, Inc. Share Price

NASDAQ: HURA | Micro Cap
$2.08
+$0.09 (4.52%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

TuHURA Biosciences, Inc. Stock Performance

Open
$2.02
Prev. Close
$1.99
Circuit Range
N/A
Day Range
$1.99 - $2.06
Year Range
$0.42 - $3.43
Volume
12,485
Average Traded
$2.03

TuHURA Biosciences, Inc. Share Price Today

As of 30 October 2026, TuHURA Biosciences, Inc.'s share price is $2.08. The stock opened at $2.02, compared to its previous close of $1.99. During today's trading session, TuHURA Biosciences, Inc.'s share price traded between $1.99 and $2.06, with an average price of $2.02. Over the past 52 weeks, the stock has recorded a high of $3.43 and a low of $0.42. In terms of performance, TuHURA Biosciences, Inc.'s share price has declined by 7.56% over the last six months and is down 18.75% on a year-on-year basis.

TuHURA Biosciences, Inc. Share Price Chart

Line chart of the TuHURA Biosciences, Inc. price trend over the selected period. The price rose overall, ranging from 1.99 to 2.06, ending at 2.06.
$1.99$2.06
L
Show Current Price
H

TuHURA Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$99.69M
PE Ratio (TTM)
N/A
Dividend Yield
0.01%
EPS (TTM)
$-0.48
Revenue (TTM)
$0.00
Return On Equity (TTM)
-165.57%
Profit Margin
N/A
Debt to Equity
0.28
Quarterly Earnings Growth YoY
-30.00%

TuHURA Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$7.10-$6.76-$7.54-$9.23
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A4.79%-11.54%-22.41%

TuHURA Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$22.65-$30.06
Net Profit MarginN/AN/A
Income ChangeN/A-32.72%

About TuHURA Biosciences, Inc.

TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.

TuHURA Biosciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$2.10
$2.06
-1.90%
Sep 2026
$2.08
$2.10
-2.33%
Aug 2026
$2.22
$2.15
-0.69%
Jul 2026
$2.38
$2.17
-7.68%
Jun 2026
$2.23
$2.35
+2.85%
May 2026
$2.23
$2.28
+1.33%
Apr 2026
$1.81
$2.25
+26.76%
Mar 2026
$1.62
$1.77
+6.61%
Feb 2026
$0.57
$1.67
+208.91%
Jan 2026
$0.75
$0.54
-27.94%
Dec 2025
$1.96
$0.75
-62.69%
Nov 2025
$2.47
$2.00
-21.68%

HURA Share Price FAQs